Tech Company Financing Transactions
Arine Funding Round
111 West Capital, Katalyst.Ventures and MBX Capital participated in a $29 million Series B venture round for Arine. This venture round was announced by the company on 8/17/2022.
Transaction Overview
Company Name
Announced On
8/17/2022
Transaction Type
Venture Equity
Amount
$29,000,000
Round
Series B
Investors
Proceeds Purpose
The company intends to use the funds to advance the capabilities of its platform to enable value-based care at scale, and to expand its offerings to channel partners across the value-based care continuum.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
595 Market St 1340
San Francisco, CA 94105
USA
San Francisco, CA 94105
USA
Phone
Website
Email Address
Overview
Arine's mission is to ensure that every individual receives the safest, most effective, and most appropriate treatment for their unique and evolving healthcare needs. Our team works hard every day to improve the lives of patients, their families, and their care teams. We built Arine to give pharmacists and their teams superpowers that help them identify people who need intervention and what intervention each person needs to stay well. By combining data science with clinical expertise, we can make healthcare better for all.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Yoona Kim
Chief Financial Officer
Eric Carlson
Chief Technical Officer
Penjit Moorhead
Browse more venture capital transactions:
Prev: 8/17/2022: Pomelo venture capital transaction
Next: 8/17/2022: Incredible Health venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs